Left ventricular (LV) dysfunction c-kit-positive, lineage-negative cardiac stem cells (CSC) improving post-infarction when given to animals. We conducted an experiment phase 1 (Stem Cell Infusion in Patients with ischemic cardiomyopathy [Scipio]) from autologous CSC for the treatment of heart failure due to ischemic heart disease.In trial stage A Scipio, patients with post-infarction LV dysfunction (ejection fraction [EF] ≤ 40%) prior to coronary artery bypass grafting were consecutively enrolled in the treatment and control groups. In stage B, patients were randomly assigned to treatment or control groups in a ratio of 2: 3 by using the block scheme of computer-generated randomization. 1 million autologous CSC given by intracoronary infusion at an average of 113 days (SE 4) after surgery; untreated controls.
Although this study is an open label, echocardiographic analysis did not know the duties of the group. The primary endpoint was a short-term security of CSC and the secondary endpoint was efficacy. A per-protocol analysis were used. This study is registered with ClinicalTrials.gov, number NCT00474461.This study is still in progress. 16 patients were assigned to the treatment group and seven for the control group; no side effects were reported related CSC.
On 14 CSC-treated patients were analyzed, LVEF increased from 30 · 3% (SE 1 · 9) before CSC infusion to 38 · 5% (2 · 8) at 4 months after infusion (p = 0 · 001). In contrast, the seven control patients, as long as the appropriate time interval, LVEF did not change (30 · 1% [2 · 4] at 4 months after CABG vs 30 · 2% [2 · 5] at 8 months after CABG). Importantly, CSC healthful effects are even more pronounced in the first year in eight patients (eg, LVEF increased by 12 · 3 unit ejection fraction [2 · 1] vs baseline, p = 0 · 0007).
In seven patients treated in whom cardiac MRI can be done, infarct size decreased from 32 · 6 g (6 · 3) by 7 · 8 g (1 · 7; 24%) at 4 months (p = 0 · 004) and 9 · 8 g (3 · 5; 30%) at 1 year (p = 0 · 04) .This preliminary results in patients with very encouraging. They suggest that intracoronary infusion of autologous CSC effective in improving LV systolic function and reduced infarct size in patients with heart failure after myocardial infarction, and warrant further, larger, phase 2 studies.University of Louisville Research Foundation and the National Institutes of Health ,
D-Luciferin sodium salt |
B8311-200 |
ApexBio |
200 mg |
EUR 838.8 |
D-Luciferin sodium salt |
B8311-50 |
ApexBio |
50 mg |
EUR 351.6 |
D-Luciferin, Sodium Salt |
7902-100 |
Biovision |
each |
EUR 144 |
D-Luciferin, Sodium Salt |
7902-10G |
Biovision |
each |
EUR 2890.8 |
D-Luciferin, Sodium Salt |
7902-10PK |
Biovision |
each |
EUR 3315.6 |
D-Luciferin, Sodium Salt |
7902-1G |
Biovision |
each |
EUR 424.8 |
D-Luciferin, Sodium Salt |
7902-25G |
Biovision |
each |
Ask for price |
D-Luciferin, Sodium Salt |
7902-3PK |
Biovision |
each |
EUR 1110 |
D-Luciferin, Sodium Salt |
7902-50G |
Biovision |
each |
Ask for price |
D-Luciferin, Sodium Salt |
7902-5PK |
Biovision |
each |
EUR 1795.2 |
D-Luciferin, Potassium Salt |
D0510-010 |
GenDepot |
100mg |
EUR 222 |
D-Luciferin, Potassium Salt |
D0510-050 |
GenDepot |
500mg |
EUR 604.8 |
D-Luciferin, Potassium Salt |
D0510-100 |
GenDepot |
1g |
EUR 1016.4 |
D-Luciferin, potassium salt |
10101 |
Biotium |
10MG |
EUR 134.4 |
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, potassium salt |
10101-1 |
Biotium |
50MG |
EUR 280.8 |
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, potassium salt |
10101-2 |
Biotium |
1G |
EUR 856.8 |
Description: Minimum order quantity: 1 unit of 1G |
D-Luciferin, Potassium Salt |
7903-100 |
Biovision |
each |
EUR 144 |
D-Luciferin, Potassium Salt |
7903-10G |
Biovision |
each |
EUR 2890.8 |
D-Luciferin, Potassium Salt |
7903-10PK |
Biovision |
each |
EUR 3315.6 |
D-Luciferin, Potassium Salt |
7903-1G |
Biovision |
each |
EUR 424.8 |
D-Luciferin, Potassium Salt |
7903-25G |
Biovision |
each |
Ask for price |
D-Luciferin, Potassium Salt |
7903-3PK |
Biovision |
each |
EUR 1110 |
D-Luciferin, Potassium Salt |
7903-50G |
Biovision |
each |
Ask for price |
D-Luciferin, Potassium Salt |
7903-5PK |
Biovision |
each |
EUR 1795.2 |
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12509 |
AAT Bioquest |
25 mg |
EUR 138 |
|
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12510 |
AAT Bioquest |
100 mg |
EUR 158.4 |
|
D-Luciferin, sodium salt *CAS#: 103404-75-7* |
12511 |
AAT Bioquest |
1 g |
EUR 633.6 |
|
CoviDrop SARS-CoV-2 Spike-ACE2 Binding Inhibitor Screening Fast Kit |
D-1004 |
EpiGentek |
|
|
CoviDrop SARS-CoV-2 Spike-ACE2 Binding Activity/Inhibition Assay Kit |
D-1005 |
EpiGentek |
|
|
CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Inhibitor Screening Fast Kit |
D-1006 |
EpiGentek |
|
|
CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Activity/Inhibition Assay Kit |
D-1007 |
EpiGentek |
|
|
SeroFlash SARS-CoV-2 Neutralizing Antibody Assay Fast Kit |
D-1008 |
EpiGentek |
|
|
CoviDrop SARS-CoV-2 Specific Furin Cleavage Site (Wild Type) Blocker/Inhibitor Screening Kit |
D-1009 |
EpiGentek |
|
|
CoviDrop SARS-CoV-2 Specific Furin Cleavage Site (P681R Mutation) blocker/Inhibitor Screening Kit |
D-1010 |
EpiGentek |
|
|
EZSolution? D-Luciferin, Potassium Salt |
B3001-set |
Biovision |
each |
EUR 444 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-10PK |
Biovision |
each |
EUR 2721.6 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-1G |
Biovision |
each |
EUR 392.4 |
Brite-Light? D-Luciferin, Potassium Salt |
B3000-5PK |
Biovision |
each |
EUR 1560 |
D-Luciferin |
B6040-10 |
ApexBio |
10 mg |
EUR 157.2 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin |
B6040-200 |
ApexBio |
200 mg |
EUR 838.8 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin |
B6040-50 |
ApexBio |
50 mg |
EUR 351.6 |
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP. |
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12505 |
AAT Bioquest |
25 mg |
EUR 138 |
|
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12506 |
AAT Bioquest |
100 mg |
EUR 158.4 |
|
D-Luciferin, potassium salt *CAS#: 115144-35-9* |
12507 |
AAT Bioquest |
1 g |
EUR 315.6 |
|
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-10 |
ApexBio |
10 mg |
EUR 247.2 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-25 |
ApexBio |
25 mg |
EUR 405.6 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-5 |
ApexBio |
5 mg |
EUR 158.4 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 17-(?-D-Glucuronide) (sodium salt) |
C3840-50 |
ApexBio |
50 mg |
EUR 602.4 |
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-1 |
ApexBio |
1 mg |
EUR 141.6 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-10 |
ApexBio |
10 mg |
EUR 632.4 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-25 |
ApexBio |
25 mg |
EUR 1287.6 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
Estradiol 3-(?-D-Glucuronide) (sodium salt) |
C3897-5 |
ApexBio |
5 mg |
EUR 367.2 |
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2]. |
D-Glucuronic acid, sodium salt, monohydrate |
GB0483 |
Bio Basic |
5g |
EUR 128.9 |
|
D-Luciferin, free acid |
10100 |
Biotium |
10MG |
EUR 134.4 |
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, free acid |
10100-1 |
Biotium |
50MG |
EUR 280.8 |
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, free acid |
10100-2 |
Biotium |
1G |
EUR 856.8 |
Description: Minimum order quantity: 1 unit of 1G |
D-Luciferin (Free acid) |
2779-1000 |
Biovision |
each |
EUR 405.6 |
D-Luciferin (Free acid) |
2779-250 |
Biovision |
each |
EUR 210 |
D-Luciferin (Free acid) |
2779-500 |
Biovision |
each |
EUR 301.2 |
D-Luciferin (Free acid) |
2779-5000 |
Biovision |
each |
EUR 1527.6 |
CAPS, sodium salt |
CB0097 |
Bio Basic |
50g |
EUR 86.1 |
|
CAPSO, sodium salt |
CD0041 |
Bio Basic |
50g |
EUR 91.32 |
|
Hepes, Sodium Salt |
CH039 |
ABM |
25 g |
EUR 141.6 |
Hepes, Sodium Salt |
CH040 |
ABM |
100 g |
EUR 202.8 |
Hepes, Sodium Salt |
CH041 |
ABM |
500 g |
EUR 448.8 |
Cefamandole sodium salt |
C079-100MG |
TOKU-E |
100 mg |
EUR 177.6 |
Cefamandole sodium salt |
C079-500MG |
TOKU-E |
500 mg |
EUR 568.8 |
Ampicillin, Sodium Salt |
A4004-005 |
GenDepot |
5g |
EUR 111.6 |
Ampicillin, Sodium Salt |
A4004-025 |
GenDepot |
25g |
EUR 206.4 |
Ampicillin, Sodium Salt |
A4004-100 |
GenDepot |
100g |
EUR 370.8 |
Narasin (sodium salt) |
C3061-25 |
ApexBio |
25 mg |
EUR 804 |
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic. |
Narasin (sodium salt) |
C3061-5 |
ApexBio |
5 mg |
EUR 224.4 |
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic. |
Methicillin (sodium salt) |
C3238-100 |
ApexBio |
100 mg |
EUR 174 |
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls. |
Methicillin (sodium salt) |
C3238-250 |
ApexBio |
250 mg |
EUR 271.2 |
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls. |
Methicillin (sodium salt) |
C3238-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls. |
Methicillin (sodium salt) |
C3238-50 |
ApexBio |
50 mg |
EUR 129.6 |
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls. |
Ertapenem (sodium salt) |
C3451-10 |
ApexBio |
10 mg |
EUR 289.2 |
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1]. |
Ertapenem (sodium salt) |
C3451-25 |
ApexBio |
25 mg |
EUR 537.6 |
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1]. |
Ertapenem (sodium salt) |
C3451-5 |
ApexBio |
5 mg |
EUR 195.6 |
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1]. |
Cefoxitin (sodium salt) |
C4849-1000 |
ApexBio |
1 g |
EUR 289.2 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Cefoxitin (sodium salt) |
C4849-250 |
ApexBio |
250 mg |
EUR 135.6 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Cefoxitin (sodium salt) |
C4849-500 |
ApexBio |
500 mg |
EUR 196.8 |
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2]. |
Fosmidomycin (sodium salt) |
C4898-10 |
ApexBio |
10 mg |
EUR 498 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Fosmidomycin (sodium salt) |
C4898-25 |
ApexBio |
25 mg |
EUR 996 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Fosmidomycin (sodium salt) |
C4898-5 |
ApexBio |
5 mg |
EUR 292.8 |
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces. |
Cefsulodin (sodium salt) |
C5593-1000 |
ApexBio |
1 g |
EUR 268.8 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Cefsulodin (sodium salt) |
C5593-250 |
ApexBio |
250 mg |
EUR 147.6 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Cefsulodin (sodium salt) |
C5593-500 |
ApexBio |
500 mg |
EUR 216 |
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1]. |
Furegrelate (sodium salt) |
C5692-10 |
ApexBio |
10 mg |
EUR 204 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Furegrelate (sodium salt) |
C5692-5 |
ApexBio |
5 mg |
EUR 134.4 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Furegrelate (sodium salt) |
C5692-50 |
ApexBio |
50 mg |
EUR 661.2 |
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2. |
Ampicillin Sodium Salt |
AK0839-0010 |
Akron Biotech |
10g |
Ask for price |
Ampicillin Sodium Salt |
AK0839-0025 |
Akron Biotech |
25g |
Ask for price |
Ampicillin Sodium Salt |
AK0839-0100 |
Akron Biotech |
100g |
Ask for price |
Simvastatin (sodium salt) |
C4426-100 |
ApexBio |
100 mg |
EUR 470.4 |
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs. |
Simvastatin (sodium salt) |
C4426-25 |
ApexBio |
25 mg |
EUR 235.2 |
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs. |
Moniliformin (sodium salt) |
C4459-1 |
ApexBio |
1 mg |
EUR 385.2 |
Description: Moniliformin induces mitotic arrest at the metaphase stage.Mitosis is a part of the cell cycle when replicated chromosomes are separated into two new nuclei. |
Cefotaxime (sodium salt) |
C4588-1000 |
ApexBio |
1 g |
EUR 151.2 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-500 |
ApexBio |
500 mg |
EUR 129.6 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Cefotaxime (sodium salt) |
C4588-5000 |
ApexBio |
5 g |
EUR 181.2 |
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic. |
Lorglumide (sodium salt) |
C4809-25 |
ApexBio |
25 mg |
EUR 174 |
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] . |
Lorglumide (sodium salt) |
C4809-50 |
ApexBio |
50 mg |
EUR 205.2 |
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] . |
Cefamandole (sodium salt) |
C3541-100 |
ApexBio |
100 mg |
EUR 292.8 |
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium". |
Cefamandole (sodium salt) |
C3541-50 |
ApexBio |
50 mg |
EUR 182.4 |
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium". |
Cefamandole (sodium salt) |
C3541-500 |
ApexBio |
500 mg |
EUR 710.4 |
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium". |
Cefonicid (sodium salt) |
C3812-1000 |
ApexBio |
1 g |
EUR 487.2 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefonicid (sodium salt) |
C3812-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefonicid (sodium salt) |
C3812-500 |
ApexBio |
500 mg |
EUR 301.2 |
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins. |
Cefoperazone (sodium salt) |
C3913-10000 |
ApexBio |
10 g |
EUR 483.6 |
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1]. |
Cefoperazone (sodium salt) |
C3913-5000 |
ApexBio |
5 g |
EUR 320.4 |
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1]. |
Moxalactam (sodium salt) |
C4121-1000 |
ApexBio |
1 g |
EUR 270 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-250 |
ApexBio |
250 mg |
EUR 134.4 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Moxalactam (sodium salt) |
C4121-500 |
ApexBio |
500 mg |
EUR 201.6 |
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis. |
Cefazolin (sodium salt) |
C4183-1000 |
ApexBio |
1 g |
EUR 201.6 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-250 |
ApexBio |
250 mg |
EUR 126 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 135.6 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Cefazolin (sodium salt) |
C4183-500 |
ApexBio |
500 mg |
EUR 165.6 |
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1]. |
Tazobactam (sodium salt) |
C4245-1000 |
ApexBio |
1 g |
EUR 271.2 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Tazobactam (sodium salt) |
C4245-250 |
ApexBio |
250 mg |
EUR 139.2 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Tazobactam (sodium salt) |
C4245-500 |
ApexBio |
500 mg |
EUR 201.6 |
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. |
Thyroxine (Sodium salt) |
30-AT52 |
Fitzgerald |
1 gram |
EUR 422.4 |
Description: High purity Thyroxine sodium salt |
Triiodothyronine (Sodium salt) |
30-AT53 |
Fitzgerald |
1 gram |
EUR 1018.8 |
Description: High purity (>99%) Triiodothyronine sodium salt |
Cefotaxime Sodium Salt |
20-abx082178 |
Abbexa |
|
|
|
PIPES Sodium Salt |
20-abx082438 |
Abbexa |
|
|
|
Carboxymethylcellulose sodium salt |
abx082467-100g |
Abbexa |
100 g |
EUR 226.8 |
|
Ampicillin Sodium Salt |
abx082587-5g |
Abbexa |
5 g |
EUR 210 |
|
Sivelestat sodium salt |
A4430-10 |
ApexBio |
10 mg |
EUR 205.2 |
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro. |
Sivelestat sodium salt |
A4430-25 |
ApexBio |
25 mg |
EUR 408 |
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro. |
Sivelestat sodium salt |
A4430-5 |
ApexBio |
5 mg |
EUR 141.6 |
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro. |
Sivelestat sodium salt |
A4430-50 |
ApexBio |
50 mg |
EUR 673.2 |
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro. |
Fostriecin sodium salt |
A4536-.1 |
ApexBio |
100 µg |
EUR 584.4 |
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively. |
Fostriecin sodium salt |
A4536-.5 |
ApexBio |
500 µg |
EUR 1762.8 |
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively. |
Cefotaxime Sodium Salt |
abx188641-100g |
Abbexa |
100 g |
EUR 610.8 |
|
Tianeptine Sodium Salt |
abx188914-25g |
Abbexa |
25 g |
EUR 376.8 |
|
Sulfamerazine sodium salt |
B3430-100000 |
ApexBio |
100 g |
EUR 164.4 |
Description: Sulfamerazine Sodium is a sulfonamide antibacterial. |
Sulfamerazine sodium salt |
B3430-50000 |
ApexBio |
50 g |
EUR 132 |
Description: Sulfamerazine Sodium is a sulfonamide antibacterial. |